HowardA.LiebmanMDMA

PubMed

• 1 citations
  Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP.
  Ilene Ceil Weitz, Howard Allen Liebman> ;British Journal of Haematology. 2023 Oct 1
• 4 citations
  Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia.
  Hanny Al-Samkari, Debbie Jiang, Terry Gernsheimer, Howard Liebman, Susie Lee, Chelsea Bernheisel, Matthew Wojdyla, Michael Vredenburg, Adam Cuker> ;Research and Practice in Thrombosis and Haemostasis. 2023 Mar 1
• Rilzabrutinibplacebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study.
  David J Kuter, James B Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P Lambert, Michelle Lee, Hailing Guo, Ahmed Daak, Liebman, H., Tarantino, M.> ;Therapeutic Advances in Hematology. 2023 Jan 1
• 3 citations
  The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related dise...
  Spencer Boyle, Ashley Hagiya, Minh-Vu H Nguyen, Howard Liebman, Jin Sol G Lee> ;Allergy, Asthma, and Clinical Immunology. 2022 Sep 9
• 28 citations
  Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.
  Hanny Al-Samkari, Debbie Jiang, Terry Gernsheimer, Howard Liebman, Susie Lee, Matthew Wojdyla, Michael Vredenburg, Adam Cuker> ;British Journal of Haematology. 2022 May 1
• 39 citations
  SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients.
  Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig M. Kessler, Caroline Kruse, Andrew D. Le...> ;Blood. 2021 Sep 29
• 13 citations
  Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern.
  Adam Cuker, Howard A. Liebman> ;Research and Practice in Thrombosis and Haemostasis. 2021 Aug 1
• 5 citations
  Nattokinase atherothrombotic prevention study: A randomized controlled trial.
  Howard N. Hodis, Wendy J. Mack, Herbert J. Meiselman, Vijay K. Kalra, Howard A. Liebman, Juliana Hwang-Levine, Laurie Dustin, Naoko Kono, Melissa Mert, Rosalinda B. We...> ;Clinical Hemorheology and Microcirculation. 2021 Jan 1
• 8 citations
  Understanding Immune Thrombocytopenia: Looking Out of the Box.
  Alexandra Schifferli, Franco Cavalli, Bertrand Godeau, Howard A. Liebman, Mike Recher, Paul Imbach, Thomas Kühne> ;Frontiers in Medicine. 2021 Jan 1
• 12 citations
  Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method
  Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard A. Liebman, Roger M. Lyons, Keith R. McCrae, Vinod Pullarkat, Jeffrey S. ...> ;Research and Practice in Thrombosis and Haemostasis. 2021 Jan 1
• 24 citations
  Prediction and Prevention of Cancer-Associated Thromboembolism.
  Alok A. Khorana, Maria T. DeSancho, Howard A. Liebman, Rachel P. Rosovsky, Jean M. Connors, Jeffrey I. Zwicker> ;The Oncologist. 2021 Jan 1
• Are Tpo agonists an option for ITP in pregnancy
  Howard A. Liebman> ;Blood. 2020 Dec 24
• 1 citations
  Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.
  Melody Hermel, David Hermel, Saif Azam, Jerold Shinbane, Annahita Sarcon, Erika Jones, Arjun Mehta, Luanda Grazette, Howard Liebman, Ilene Weitz> ;Ejhaem. 2020 Jul 1
• 799 citations
  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
  Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Y. Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Charles W. Fra...> ;Journal of Clinical Oncology. 2020 Feb 10
• 88 citations
  Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
  Adrian C. Newland, Blanca Sanchez-Gonzalez, László Rejtő, Miklos Egyed, Nataliya Romanyuk, Marie Godar, Katrien Verschueren, Domenica Gandini, Peter Ulrichts, Jon Beau...> ;American Journal of Hematology. 2020 Feb 1
• 4 citations
  A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic A...
  Caroline I. Piatek, Hillel Bocian, Sandra Algaze, Ilene C. Weitz, Casey O'Connell, Howard A. Liebman> ;Acta Haematologica. 2020 Jan 1
• 13 citations
  A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia
  Adrian Newland, Roy Bentley, Anna Jakubowska, Howard A. Liebman, Joanna Lorens, Markus Peck-Radosavljevic, Vanessa Taieb, Akiyoshi Takami, Ryosuke Tateishi, Zobair M. ...> ;Hematology. 2019 Oct 3
• 364 citations
  2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
  Dominique Farge, Corinne Frere, Jean M. Connors, Cihan Ay, Alok A. Khorana, Andrés Muñoz, Benjamin Brenner, Ajay K. Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilh...> ;The Lancet. Oncology. 2019 Oct 1
• 19 citations
  Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.
  Lamya Garabet, Waleed Ghanima, Christine M. Jonassen, Vibe Skov, René Holst, Marie-Christine Mowinckel, Hans Carl Hasselbalch, Torben A Kruse, Mads Thomassen, Howard A...> ;Platelets. 2019 Feb 17
• 96 citations
  Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
  Jeffrey I. Zwicker, Benjamin L. Schlechter, Jack D. Stopa, Howard A. Liebman, Anita Aggarwal, Maneka Puligandla, Thomas Caughey, Kenneth A. Bauer, Nancy B. Kuemmerle, ...> ;JCI Insight. 2019 Feb 21
• 13 citations
  Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center
  Caitlin O'Neill, Ilene C. Weitz, Casey O'Connell, Howard A. Liebman> ;Platelets. 2019 Jan 1
• 4 citations
  Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk
  Howard A. Liebman> ;Thrombosis Research. 2018 Apr 1
• 4 citations
  Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial.
  Khorana, A. A., Vadhan-Raj, S., Kuderer, N. M., Wun, T., Liebman, H. A., Soff, G. A., Belani, C. P., O'Reilly, E. M., McBane, R. D., Eikelboom, J. W., Damaraju, C. V.,...> ;Thrombosis and haemostasis. 2017 Dec 5
• 6 citations
  Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study
  Davendra Sohal, Nicole M. Kuderer, Frances A. Shepherd, Ingrid Pabinger, Giancarlo Agnelli, Howard A. Liebman, Guy Meyer, Matthew F. Kalady, Keith R. McCrae, Gary H. L...> ;JNCI Cancer Spectrum. 2017 Sep 1
• 57 citations
  Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
  Nicole M. Kuderer, Marek S. Poniewierski, Eva Culakova, Gary H. Lyman, Alok A. Khorana, Ingrid Pabinger, Giancarlo Agnelli, Howard A. Liebman, Eric Vicaut, Guy Meyer, ...> ;The Oncologist. 2018 Feb 1
• Join now to see all

Abstracts/Posters

• Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia
  Howard A. Liebman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019